| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |